These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4764537)

  • 1. Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
    Sotaniemi EA
    Pharmacology; 1973; 10(5):306-16. PubMed ID: 4764537
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipyrine metabolite kinetics in phenobarbital and beta-naphthoflavone-induced rats.
    Rhodes JC; Houston JB
    Drug Metab Dispos; 1983; 11(2):131-6. PubMed ID: 6133717
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14C-antipyrine as a model compound in the study of drug oxidation and enzyme induction in individual surviving rats.
    Bakke OM; Bending M; Aarbakke J; Davies DS
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):91-7. PubMed ID: 4479350
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
    Tse FL; Chang T; Jaffe JM
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone--a weak enzyme inducer in man.
    Taylor SA; Rawlins MD; Smith SE
    J Pharm Pharmacol; 1972 Jul; 24(7):578-9. PubMed ID: 4403853
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of various neuroleptics, phenobarbital and SKF 525-A on dimethyltryptamine content in rat brain and liver.
    Wang Lu LJ; Demetriou SK; Domino EF
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):117-33. PubMed ID: 27150
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of drug pretreatment on antipyrine elimination in the rabbit.
    Chambers DM; Jefferson GC
    Pharmacology; 1982; 24(2):88-95. PubMed ID: 7079291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phenobarbital steady state levels on antipyrine clearance and distribution in the rat.
    Pei YY; Bialer M; Levy RH
    Biopharm Drug Dispos; 1986; 7(1):11-9. PubMed ID: 3955196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.
    Shaw PN; Houston JB; Rowland M; Hopkins K; Thiercelin JF; Morselli PL
    Br J Clin Pharmacol; 1985 Dec; 20(6):611-8. PubMed ID: 4091993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A re-evaluation of intersubject variation in enzyme induction in man.
    Branch RA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):104-10. PubMed ID: 455871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-protein binding: a method for studying the interactions of drugs with bishydroxycoumarin (dicoumarol) in dogs.
    Welch RM
    Ann N Y Acad Sci; 1973 Nov; 226():259-66. PubMed ID: 4129139
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
    McManus ME; Ilett KF
    Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enhanced drug hydroxylation in man under diphenyl-hydantoin therapy].
    Petruch F; Schüppel RV
    Arzneimittelforschung; 1974 Jul; 24(7):1023-5. PubMed ID: 4211429
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzyme induction in sheep: effects of phenobarbital on in vivo and in vitro drug metabolism.
    Shetty SN; Himes JA; Edds GT
    Am J Vet Res; 1972 May; 33(5):935-42. PubMed ID: 4112405
    [No Abstract]   [Full Text] [Related]  

  • 16. SKF 525-A inhibition of hepatic monooxygenase activity in rhesus monkeys.
    Clark CR; Gee SJ; Krieger RI
    Pharmacology; 1978; 17(4):201-9. PubMed ID: 99753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF; Skinner MH; Blaschke TF
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic tolerance of a new anticonvulsant agent (3-sulfamoylmethyl-1,2-benzisoxazole) compared to phenobarbital, diphenylhydantoin and carbamazepine in rats.
    Masuda Y; Utsui Y; Shiraishi Y; Karasawa T; Yoshida K; Shimizu M
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):79-89. PubMed ID: 507999
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of phenobarbital on the metabolism and serotonin-depleting action of 4-chloro-beta, beta-difluoroamphetamine in rats.
    Fuller RW; Baker JC; Perry KW; Molloy BB
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):274-8. PubMed ID: 4851682
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.